August, 19 2025 Tuesday 11:36 Hrs
  • SENSEX :   81,501.25

  • Commodity broking firm in India227.50( 0.28%) 19-Aug-2025
top-arrow-market
Sensex 81503.82 230.07  (0.28) 19-Aug-2025
Previous Day Close
81273.75
Today's High/Low
High Low
  •  
  •  
81520.45 81315.44

Hot Pursuit - Detailed News

Marksans Pharma rises as UK subsidiary gets approval for Metformin Prolonged release tablets
18-Aug-25   15:45 Hrs IST
The approval was granted by the UK regulatory authorities, allowing Relonchem to market the widely used anti-diabetic medication in three dosage strengths. Metformin is commonly prescribed for the treatment of type 2 diabetes and is considered a frontline therapy for managing blood glucose levels.

Marksans Pharma is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations.

The company's consolidated net profit dropped 34.3% to Rs 58.31 crore despite of 4.97% jump in revenue from operations to Rs 619.98 crore in Q1 FY26 over Q1 FY25.

Powered by Capital Market - Live News

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.